Why Security Of Supply Is Key To Improving Global Supply Chain Resilience – And Where We Can Start

By Vikki Ponting

Following years of supply chain instability in the biopharma and life sciences sectors due to COVID-19, extensive protective measures have been implemented locally, regionally, and globally.

However, despite greater efforts to secure global supply chains, the threat of economic challenges, future pandemics, and the growing complexity of therapeutic formulations and workflows continues to raise concerns surrounding the ability of manufacturers to meet long-term demand.

Explore the past, present, and future of supply chain security, ways the biopharma industry can secure supply chains and minimize risks, and more.